Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Singleron (Nanjing) Biotechnologies Ltd. holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio contains 3 pending office actions. These matters are assigned to 3 distinct examiners across 2 distinct art units. GOLDBERG, JEANINE ANNE is the busiest examiner, with 1 pending office action. The 3 pending office actions are spread across 3 distinct examiners, meaning each case is being handled by a different individual. This distribution suggests that the company is experiencing a variety of examiner styles within the Biotechnology & Pharmaceuticals field.
The presence of 2 distinct art units indicates that the technology is being classified into different specialized groups. GOLDBERG, JEANINE ANNE, as the busiest examiner with 1 pending office action, handles a portion of the 3 pending office actions. This diversity in examiners and art units requires a flexible prosecution strategy to address the 3 pending office actions. Practitioners should note that the workload is spread across multiple individuals, which provides an opportunity to test different arguments across the portfolio. Managing 3 distinct examiners requires careful coordination to move the 3 pending office actions forward.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLDBERG, JEANINE ANNE | 1 | 45.8% | +40.8% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
| BOESEN, CHRISTIAN C | 1 | 75.9% | +21.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
| 18251147 | A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING | GOLDBERG, JEANINE ANNE | 61d |
| 17996195 | METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS | BOESEN, CHRISTIAN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 126d overdue |
| 18251147 | A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING | GOLDBERG, JEANINE ANNE | 61d |
| 17996195 | METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS | BOESEN, CHRISTIAN C | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18251147 | A METHOD FOR SINGLE-CELL NASCENT RNA LABELING AND SEQUENCING | GOLDBERG, JEANINE ANNE | 1682 | §103§112 | Final Rejection | 61d | Pending | Apr 28, 2023 |
| 17996196 | A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS | PARISI, JESSICA DANIELLE | 1684 | §102§112 | Final Rejection | 126d overdue | Pending | Oct 13, 2022 |
| 17996195 | METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT TARGET SEQUENCING IN SINGLE CELLS | BOESEN, CHRISTIAN C | 1684 | §101§102 | Non-Final OA | — | Pending | Oct 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial